Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Background Allogeneic stem cell transplantation (allo-SCT) is widely regarded as the most effective consolidation treatment for patients with intermediate to high-risk ELN AML. However, despite its potential curative benefits, many elderly patients (aged ≥60) are unable to undergo this procedure due...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.1513-1513
Hauptverfasser:	Russo, Domenico, Polverelli, Nicola, Santarone, Stella, Onida, Francesco, Castagna, Luca, Bramanti, Stefania, Carella, A. M., Sorasio, Roberto, Olivieri, Attilio, Beltrami, Germana, Curti, Antonio, Vetro, Calogero, Mancini, Valentina, Terruzzi, Elisabetta, Bernardi, Massimo, Galieni, Piero, Musto, Pellegrino, Cerretti, Raffaella, Giaccone, Luisa, Skert, Cristina, Borlenghi, Erika, Farina, Mirko, Leoni, Alessandro, Radici, Vera, Bernardi, Simona, Vezzoli, Marika, Calza, Stefano, Gheorghiu, Angela, Malagola, Michele, Martino, Massimo, Ciceri, Fabio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!